<?xml version="1.0" encoding="UTF-8"?>
<ref id="B197-ijms-21-04546">
 <label>197.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liniger</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zuniga</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Tamin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Azzouz-Morin</surname>
    <given-names>T.N.</given-names>
   </name>
   <name>
    <surname>Knuchel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Marty</surname>
    <given-names>R.R.</given-names>
   </name>
   <name>
    <surname>Wiegand</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Weibel</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kelvin</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Rota</surname>
    <given-names>P.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses</article-title>
  <source>Vaccine</source>
  <year>2008</year>
  <volume>26</volume>
  <fpage>2164</fpage>
  <lpage>2174</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2008.01.057</pub-id>
  <pub-id pub-id-type="pmid">18346823</pub-id>
 </element-citation>
</ref>
